INSIGHTS

As per the sources, the court in the Odisha capital, Bhuvaneshwar has admitted a petition challenging Aamir Khan Production’s plans to...

Takshasheel Bouddha, an intern at Khurana and Khurana Advocates and IP Attorneys, analyses the case, M/s Aditi Manufacturing Company v /s...

In a positive development for US drug giant Pfizer, the country’s Intellectual Property Appellate Board (IPAB) has issued an interim stay...

There has been limited judicial consideration of how patent law applies to pharmaceutical inventions in India. Little specific guidance...

I really wonder if the Indian Patent Act was already less troublesome that we needed a new set of rules, substantially increased fees,...

Trastuzumab/Herceptin has been amidst several controversaries off lately and this time it is regarding a biosimilar which has jointly...

The Patent (Amendment) Rules, 2014 has come in force with effective from 28th February 2014. The major changes are the hike in official...

This article relates to a judgment of Intellectual Property Appellate Board (hereinafter IPAB) dated 20 th January 2014 in the case “ ”...

This article relates to a recent judgment of IPAB in the case “NTT DoCoMo Inc. Vs The Controller of Patents and Designs” for a patent...

The intellectual property (IP) concepts that are applied today to the national laws and international treaties and organizations date...

Akash Patel, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at the nature of jurisdiction at the IPAB, its power and...

Gopikrishnan M and Akash Patel, interns at Khurana and Khurana, Advocates and IP Attorneys, looks at Central Government’s power of...

Sanyukta Biswas, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at the rights of singer, lyricist and composer that...

After anti–influenza drug Tamiflu (Oseltamivir Phosphate) and antiretroviral drug Viread, Gilead Sciences is again back in news, this...

India issued its first CL last year for a Bayer’s kidney liver cancer drug Nexavar to an Indian generic manufacturer Natco on all three...

The Patent (Amendment) Rules, 2013 came in force with effective from 15th October 2013. It appears that the primary aim of the amendment...

The Indian Patent Office is recognised as an International Searching Authority (ISA) and International Preliminary Examining Authority...

It was on 8’th August 2013 that the Patent Office, based on feedback from numerous stakeholders, came out with yet another draft of...

GSK’s granted patent IN221171 (‘171) on lapatinib ditosylate (marketed as Tykerb), a tyrosine kinase inhibitor for treating breast...

As per the notification of 07 th July 2013 at the Indian Patent Office, the responses to Examination Reports can now be also filed...